Cariad Chester

2.3k total citations
30 papers, 1.5k citations indexed

About

Cariad Chester is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Cariad Chester has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Immunology and 6 papers in Genetics. Recurrent topics in Cariad Chester's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (8 papers). Cariad Chester is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (8 papers). Cariad Chester collaborates with scholars based in United States, China and Canada. Cariad Chester's co-authors include Holbrook E. Kohrt, Ignacio Melero, Jun Wang, Miguel F. Sanmamed, Holden T. Maecker, Kevin T. Nead, Nicholas J. Leeper, Nigam H. Shah, Samuel Swisher‐McClure and Greg Gaskin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Cariad Chester

30 papers receiving 1.5k citations

Peers

Cariad Chester
Joud Hajjar United States
Robert Iannone United States
Ayman Oweida United States
Han Hao China
Sophie Dessureault United States
Parminder Singh United States
Pauline L. Martin United States
Jan M. Herter United States
Jahan S. Khalili United States
Joud Hajjar United States
Cariad Chester
Citations per year, relative to Cariad Chester Cariad Chester (= 1×) peers Joud Hajjar

Countries citing papers authored by Cariad Chester

Since Specialization
Citations

This map shows the geographic impact of Cariad Chester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cariad Chester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cariad Chester more than expected).

Fields of papers citing papers by Cariad Chester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cariad Chester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cariad Chester. The network helps show where Cariad Chester may publish in the future.

Co-authorship network of co-authors of Cariad Chester

This figure shows the co-authorship network connecting the top 25 collaborators of Cariad Chester. A scholar is included among the top collaborators of Cariad Chester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cariad Chester. Cariad Chester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vainshelboim, Baruch, Zhongming Chen, Peter Kokkinos, et al.. (2017). Cardiorespiratory Fitness, Adiposity, and Cancer Mortality in Men. Obesity. 25(S2). S66–S71. 9 indexed citations
2.
Zhao, Xing, et al.. (2017). Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus. PLoS ONE. 12(9). e0184816–e0184816. 7 indexed citations
3.
Vainshelboim, Baruch, Jan Müller, Ricardo Moreno Lima, et al.. (2017). Cardiorespiratory fitness, physical activity and cancer mortality in men. Preventive Medicine. 100. 89–94. 37 indexed citations
4.
Vainshelboim, Baruch, Jan Müller, Ricardo Moreno Lima, et al.. (2017). Cardiorespiratory fitness and cancer incidence in men. Annals of Epidemiology. 27(7). 442–447. 25 indexed citations
5.
Chester, Cariad, Miguel F. Sanmamed, Jun Wang, & Ignacio Melero. (2017). Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies. Blood. 131(1). 49–57. 336 indexed citations
6.
Souza-Fonseca-Guimarães, Fernando, Stephen J. Blake, Amani Makkouk, et al.. (2016). Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity. OncoImmunology. 5(7). e1192740–e1192740. 10 indexed citations
7.
Chester, Cariad, et al.. (2016). 4-1BB agonism: adding the accelerator to cancer immunotherapy. Cancer Immunology Immunotherapy. 65(10). 1243–1248. 90 indexed citations
8.
Nead, Kevin T., Greg Gaskin, Cariad Chester, et al.. (2016). Influence of age on androgen deprivation therapy-associated Alzheimer’s disease. Scientific Reports. 6(1). 35695–35695. 12 indexed citations
9.
Makkouk, Amani, Cariad Chester, & Holbrook E. Kohrt. (2016). Rationale for anti-CD137 cancer immunotherapy. European Journal of Cancer. 54. 112–119. 65 indexed citations
10.
Yonezawa, Atsushi, Cariad Chester, Narendiran Rajasekaran, & Holbrook E. Kohrt. (2016). Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 Ab.. PubMed. 5(1). 5–5. 5 indexed citations
11.
Zhao, Xing, Cariad Chester, Narendiran Rajasekaran, Zhixu He, & Holbrook E. Kohrt. (2016). Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus. Molecular Cancer Therapeutics. 15(5). 767–773. 50 indexed citations
12.
Chester, Cariad, Oliver Dorigo, Jonathan S. Berek, & Holbrook E. Kohrt. (2015). Immunotherapeutic approaches to ovarian cancer treatment. Journal for ImmunoTherapy of Cancer. 3(1). 7–7. 59 indexed citations
13.
Chester, Cariad, Aurélien Marabelle, Roch Houot, & Holbrook E. Kohrt. (2015). Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors. Current Opinion in Immunology. 33. 1–8. 24 indexed citations
14.
Chester, Cariad, et al.. (2015). Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy. Frontiers in Immunology. 6. 601–601. 147 indexed citations
15.
Kohrt, Holbrook E., Narendiran Rajasekaran, Cariad Chester, Atsushi Yonezawa, & Xing Zhao. (2015). Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment. ImmunoTargets and Therapy. 4. 91–91. 48 indexed citations
16.
Makkouk, Amani, Vandana Sundaram, Manisha Desai, et al.. (2015). Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P98–P98. 1 indexed citations
17.
Nead, Kevin T., et al.. (2015). Using clinical data text-mining analysis to examine the association between androgen deprivation therapy and depression.. Journal of Clinical Oncology. 33(15_suppl). e12595–e12595. 1 indexed citations
18.
Nead, Kevin T., Greg Gaskin, Cariad Chester, et al.. (2015). Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk. Journal of Clinical Oncology. 34(6). 566–571. 147 indexed citations
19.
Chester, Cariad & Holden T. Maecker. (2015). Algorithmic Tools for Mining High-Dimensional Cytometry Data. The Journal of Immunology. 195(3). 773–779. 72 indexed citations
20.
Sagiv-Barfi, Idit, Debra K. Czerwinski, Serena Chang, et al.. (2014). Abstract 2941: Local tumor irradiation combined with α-PDL-1 immune checkpoint inhibition results in local and systemic anti-tumor responses: Successful translation of a mouse model to a human case series. Cancer Research. 74(19_Supplement). 2941–2941. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026